KEY FEATURES
| Full Name | Endocrine Gland Derived Vascular Endothelial Growth Factor |
|---|---|
| Synonym | PK1; EGVEGF; PRK1, PROK1; Prokineticin 1; Black Mamba Toxin-Related Protein; Mambakine |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 15.6-1000pg/mL |
| Sensitivity | 6.5pg/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human EG-VEGF in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human EG-VEGF. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human EG-VEGF and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human EG-VEGF, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human EG-VEGF. You can calculate the concentration of Human EG-VEGF in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human EG-VEGF ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 49.99 | 130.69 | 382.93 | 53.8 | 141.44 | 400.71 |
| Standard deviation | 2.77 | 6.08 | 17.61 | 2.86 | 7.2 | 17.43 |
| CV(%) | 5.55 | 4.65 | 4.6 | 5.31 | 5.09 | 4.35 |
RECOVERY
The recovery of Human EG-VEGF spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 88-98 | 93 |
| EDTA plasma (n=8) | 83-97 | 90 |
| Cell culture media (n=8) | 88-102 | 93 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human EG-VEGF in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with LEP ELISA Kits
| LEPR ELISA Kit | publications with LEP and LEPR |
| STAT3 ELISA Kit | publications with LEP and STAT3 |
| INS ELISA Kit | publications with LEP and INS |
| GHRL ELISA Kit | publications with LEP and GHRL |
| CRP ELISA Kit | publications with LEP and CRP |
| JAK2 ELISA Kit | publications with LEP and JAK2 |
| PTPN1 ELISA Kit | publications with LEP and PTPN1 |
| SOCS3 ELISA Kit | publications with LEP and SOCS3 |
Pathways associated with LEP ELISA Kit
| AMPK Signaling Pathway | AMPK Signaling Pathway |
| Adipocytokine Signaling Pathway | Adipocytokine Signaling Pathway |
| Adipogenesis Pathway | Adipogenesis Pathway |
| Cytokine-cytokine Receptor Interaction Pathway | Cytokine-cytokine Receptor Interaction Pathway |
| Developmental Biology Pathway | Developmental Biology Pathway |
| HIF-1-alpha Transcription Factor Network Pathway | HIF-1-alpha Transcription Factor Network Pathway |
| Incretin Synthesis, Secretion, And Inactivation Pathway | Incretin Synthesis, Secretion, And Inactivation Pathway |
| Jak-STAT Signaling Pathway | Jak-STAT Signaling Pathway |
Diseases associated with LEP ELISA Kit
| Obesity | publications with LEP and Obesity |
| Pain | publications with LEP and Pain |
| Insulin Resistance | publications with LEP and Insulin Resistance |
| Hyperinsulinism | publications with LEP and Hyperinsulinism |
| Weight Gain | publications with LEP and Weight Gain |
| Cardiovascular Diseases | publications with LEP and Cardiovascular Diseases |
| Inflammation | publications with LEP and Inflammation |
| Fatty Liver | publications with LEP and Fatty Liver |
| Diabetes Mellitus, Type 2 | publications with LEP and Diabetes Mellitus, Type 2 |
| Liver Diseases | publications with LEP and Liver Diseases |
Organs/Tissues associated with LEP ELISA Kit
| Blood | publications with LEP and Blood |
| Adipose Tissue | publications with LEP and Adipose Tissue |
| Muscle | publications with LEP and Muscle |
| Connective Tissue | publications with LEP and Connective Tissue |
| Intestine | publications with LEP and Intestine |
| Placenta | publications with LEP and Placenta |
| Mouth | publications with LEP and Mouth |
| Mammary Gland | publications with LEP and Mammary Gland |
| Thymus | publications with LEP and Thymus |